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Audiograms were traced or additionally performed on 23 Usher* s syndrome patients in 10 Dutch multi-affected families, all linked 
to chromosome lq  (USH2A locus). Serial audiograms, available in 13 patients, were used for a regression analysis of binaural pure tone 
average on age (follow-up, 9 to 32 years) to test for “significant progression,*1 ie, a significant regression coefficient, here called the 
“annual threshold increase’* (ATI, expressed in decibels per year). A significant ATI (>1 dB/y) was observed in 3 patients. Analysis of 
variance o f ATI demonstrated significant heterogeneity; hearing loss was either stable or progressive. This implies a significant clinical 
heterogeneity. A similar analysis performed on our progressive USH2A cases and “type m ” cases previously reported by others (ATI 
o f 1 to 5 dB/y), some of which were recently linked to chromosome 3q (USH3 locus), failed to show any significant heterogeneity in 
the progression o f hearing loss.
KEYWORDS — deaf-blindness, gene linkage, genetic deafness, progressive deafness, retinitis pigmentosa, sensorineural hearing 
loss, type III Usher’s syndrome.
INTRODUCTION
Usher’s syndrome is an autosomal recessive disor­
der characterized by congenital sensorineural hearing 
loss (SNHL) that is combined with progressive pig­
mentary retinopathy that shows onset in childhood or 
adolescence and leads to severe constriction of the 
visual field (tunnel vision). Cataracts usually occur 
later and cause additional loss of vision, eventually up 
to the point of (sub)total blindness.
Three clinical subtypes were currently distin­
guished, before the gene linkage studies started.1-3 
Type I involves profound congenital SNHL that causes 
abnormal speech and language development, com­
bined with vestibular areflexia or severe hyporef lexia, 
which later in life adds to the problem of spatial 
disorientation as the visual system further deterio­
rates. Type II involves moderate to severe SNHL, 
most pronounced at the higher frequencies, whereas 
at the speech frequencies there generally is sufficient 
hearing ability to allow for the normal development 
of speech and language. Vestibular (caloric) responses 
can be elicited. The S NHL of this type was defined as 
stationary throughout life, apart from the develop­
ment of presbycusis at a more advanced age. A 
clinical type of Usher’s syndrome with features simi­
lar to type II, in which, however, the SNHL proved to 
be progressive, was designated as type III.
Gene linkage studies have split type I into three 
subtypes and type II into two subtypes. Type I has
been linked to loci at 14q32 (USH1A),4“6 l lq l4  
(USH1B),5’6 and 1 lp l3-15 (USH1C),6 whereas type 
IIhas been linked to lq41 (USH2A).7-9 Usher’s cases 
that fail to show linkage to chromosome lq41 are 
classified as Usher’s type 2B.10»11
This study shows the long-term results of audiom­
etry in 23 patients from 10 Dutch multi-affected 
families with Usher’s type 2A syndrome. Serial 
audiograms were collected and analyzed to evaluate 
whether the hearing loss was stable or showed sig­
nificant progression.
PATIENTS AND METHODS
Our study population comprised 23 patients from
11 different sibships in 10 kindreds with more than 1 
affected person. Blood samples from affected per­
sons and their nonaffected relatives whose medical
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TABLE 1. SUMMARY DIAGNOSTIC AND LINKAGE 
DATA FOR EACH MULTIPLEX SIBSHIP OR
KINDRED ANALYZED
TABLE 2. MULTIPOINT LOD SCORES OF DUTCH 
FAMILIES GROUPED BY AUDIOLOGIC PHENOTYPE
Family
Probability o f  
Linkage to 
lq41 Markers
Tentative
Audiologic
Phenotype
A .985 II
B ,980 II
C *972 III
D .979 II
E .979 II
F .997 Mixed
G .972 II
Hand I .993 Mixed
K .996 Mixed
M .955 II
Phenotype II is stable hearing loss, Phenotype III is progressive 
hearing loss. Mixed phenotype, phenotype III, does occur, but not —- 
with at least some certainty — in all sibs.
history indicated stable hearing loss (type II) were 
collected and analyzed at Boys Town National Re­
search Hospital for gene linkage. The following chro­
mosome 1 markers had been typed on all family 
members: D1S245, D1S70, D1S217, D1S237, 
D1S229, D1S227, PPOL, and D1S81. The Usher’s 
2A gene is flanked by a 2.4 centimorgan region 
bounded by D1S237 and D1S229.
The patient’s history was taken and a general 
otorhinolaryngological examination, including audi­
ometry and collecting previous audiograms, was per­
formed with otoscopy in all instances, and the diag­
nosis of Usher’s syndrome was confirmed by one 
ophthalmologist with assessment of the extent of 
retinitis pigmentosa, impairment of the visual fields, 
visual acuity, dark adaptation testing, and an elec- 
troretinogram. Vestibular excitability was confirmed 
with rotatory tests and caloric tests. This report will 
be limited to the evaluation of the audiometric data.
Audiometric data could be obtained from the files 
from the Nijmegen otorhinolaryngology department 
or elsewhere. In all cases clinical routine or serial 
audiometry was performed according to common 
standards and with the usual clinical equipment. 
Serial audiometry over 9 years up to 32 years was 
available in 13 patients. Most of the patients were 
also examined in the University Hospital Nijmegen, 
where pure tone audiograms were measured with an 
Interacoustics AC5 audiometer (Interacoustics, As- 
sens, Denmark), calibrated following the ISO 38912 
procedure according to the ISO 8253-1 standard13 
over the most recent years. The following tentative 
audiologic phenotypes were distinguished: type II 
(stable hearing loss), type III (progressive hearing 
loss), and “mixed” (different types occurring simul­
taneously in one family). The assignment of each
Distance From D1S237 
(centimorgans)
Group Family -10 0 +2 4-/2
II A , B , D ,  
E, G.M
2.485 3.535 3.463 2.438
m C 0.414 0.582 0.683 0.415
Mixed F, H and 
I.K
2.800 3,834 3.876 2.838
Total 5.699 7.951 8.022 5.691
sibship was established by inspecting plots of the 
binaural pure tone average (BPTA, in decibels hear­
ing level [HL]) against age; BPTA is the average of 
the pure tone averages (PTAs, at the frequencies 0.5,
1, and 2 kHz) of both sides. This tentative phenotype 
was used to test in first approximation whether it 
discriminated between the linked and unlinked sub- 
types of Usher’s type II. Statistical tests on audiologic 
data comprised a regression analysis of BPTA on age 
toseewhethertheregressioncoefficient —  herecalled
“annual threshold increase” (ATI) and expressed in 
decibels per year — differed significantly from zero 
in each individual with sufficient (n a 3) serial au­
diologic data available, and an analysis of variance of 
the ATI values to test for (non)homogeneity in type 
of hearing loss.
RESULTS
There were 11 different families and 10 different 
kindreds (the families H and I were the same kindred) 
with Usher’s type 2A. Two of the families involved 
multiple sibships of affected persons and the lod 
score data for these families represent linkage analy­
sis on the whole kindred and are not presented on an 
individual sibship basis. The heterogeneity analysis 
(Ott’s A-test) was employed to determine the prob­
ability that each family was linked to a chromosome 
lq marker set. The overall y}  was nonsignificant 
when only the 10 Dutch families were included, and 
the resulting individual probabilities of each family 
being type 2A were all estimated at 1.0. Only when 
the Dutch data were pooled with the total set of 68 
Usher II families ascertained worldwide were con­
servative probabilities obtained (the overall rate of 
heterogeneity was estimated at 12,5%). The resulting 
probabilities are shown in Table 1 and indicate that 
none of the families showed convincing nonlinkage 
with lq41 markers. Family M had the lowest prob­
ability, .955, because it was the least informative of 
all the families.
As a further test of heterogeneity, the families were 
divided into three groups, those in which most mem­
bers fit with the II phenotype with a stable hearing 
loss (families A, B, D, E, G, and M), those fitting the
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TABLE 3. HEARING LOSS, MEASURED BY BINAURAL PURE TONE AVERAGE, AND REGRESSION ON AGE AND
ASS IGNED TENTATIVE AUDIOLOGIC PHENOTYPE ___________ _ _ _ _ _ _ _
Regression Parameters
Audiologic ATI SD
Subject Sex Age and Binaural Pure Tone Average Phenotype r (dB/y) (dB/y)
A1 F 43 y 0 mo 60 dB HL; 48 y 11 mo 64 dB HL II
A2 M 31 y ? mo 54 dB HL; 44 y 11 mo 65 dB HL II
B3 M 55 y 9 mo 34 dB HL II
B4 M 24 y 5 mo 32 dB HL; 40 y 6 mo 42 dB HL; 40 y 10 mo 48 dB HL II .94 0.805 0.305
C5 F 21 y 3 mo 69 dB HL; 26 y 5 mo 73 dB HL; 31 y 10 mo 82 dB HL; 
36 y 10 mo 84 dB HL
III .97 1.04 0.172
C6 M 11 y 3 mo 52 dB HL; 13 y 5 mo 61 dB HL; 22 y 1 mo 78 dB HL; 
28 y 1 mo 82 dB HL; 33 y 7 mo 87 dB HL; 38 y 0 mo 88 dB HL
III ,95 131 0,204
D7 M 11 y 4 mo 48 dB HL; 26 y 5 mo 48 dB HL; 27 y 3 mo 53 dB HL II .54 0.174 0.271
D8 F 13 y 4 mo 47 dB HL; 22 y 0 mo 48 dB HL; 24 y 2 mo 48 dB HL II .98 0.099 0*019
E9 F 6 y 10 mo 49 dB HL; 24 y 3 mo 56 dB HL; 25 y 3 mo 58 dB HL II .99 0.450 0.075
E10 M 5 y 7 mo 35 dB HL; 13 y 3 mo 33 dB HL; 20 y 10 mo 38 dB HL II .59 0.196 0,266
F ll F 5 y 7 mo 48 dB HL; 10 y 7 mo 48 dB HL; 14 y 4 mo 54 dB HL; 
26 y 8 mo 59 dB HL; 37 y 3 mo 87 dB HL
III ,93 1.17 0,272
F12 F 32 y 5 mo 67 dB HL; 34 y 9 mo 62 dB HL II or III
F13 F 15 y 0 mo 57 dB HL; 20 y 1 mo 64 dB HL; 25 y 11 mo 64 dB HL II or m .85 0.626 0.395
G14 F 39 y 9 mo 61 dB HL; 44 y 6 mo 62 dB HL; 48 y 9 mo 62 dB HL; 
48 y 11 mo 61 dB HL
II .31 0.041 0.090
G15 M 45 y 8 mo 58 dB HL; 50 y 9 mo 66 dB HL II
HI6 F 45 y 4 mo 88 dB HL; 50 y 3 mo 89 dB HL in?
H17 F 42 y 10 mo 81 dB HL; 45 y 10 mo 86 dB HL in?
118 M 15 y 7 mo 48 dB HL; 22 y 8 mo 54 dB HL n  or 1117
119 F 5 y 4 mo 50 dB HL; 11 y 5 mo 48 dB HL; 12 y 0 mo 46 dB HL; 
21 y 3 mo 53 dB HL
ii .52 0.235 0.275
120 M 6 y 11 mo 50 dB HL; 7 y 3 mo 48 dB HL; 20 y 3 mo 56 dB HL ii .97 0,529 0,143
K24 F 40 y 2 mo 58 dB HL; 47 y 8 mo 68 dB HL; 49 y 10 mo 61 dB HL; 
51 y 9 mo 65 dB HL
ii .80 0.695 0,530
K25 F 41 y 10 mo 95 dB HL h i?
M29 M 33 y 6 mo 58 dB HL; 38 y 6 mo 62 dB HL ii
Annual threshold increase (ATI) equals regression coefficient (correlation coefficient r); SD is its standard deviation« Italics indicate significant 
difference from zero.
Ill phenotype with a progressive hearing loss (family 
C), and those that seemed to be mixtures of the two 
phenotypes (families P, H and I, and K). The lod 
scores for these three groups were summed at con­
stant positions -10, 0, +2, +12 centimorgans relative 
to marker D1S237, and the results are listed in Table
2. An M-test analysis (Morton) was carried out on the 
grouped data. The result was %2(2) = 0.20 (not signifi­
cant),14 Thus, it is concluded that dividing the sample 
into different audiologic phenotypes does not un­
cover any genetic heterogeneity of Usher’s type II. 
Thus, we would conclude that this clinical variability 
is not due to the involvement of two (USH) loci.
The available audiometric measurements are pre­
sented by age in Table 3; included is the assigned 
tentative audiologic phenotype. The mean difference 
between right and left PTA was only about 5 dB (SD 
about4 dB). A systematic study of the separate sound 
frequencies showed that the progression of hearing
loss (when present) could be regarded as being suffi­
ciently represented by the progression at the speech 
frequencies (0.5, 1, and 2 kHz), especially at 1 kHz. 
It was thus validated that the PTA (and hence the 
BPTA) was a suitable measure of the development of 
hearing loss.
Those patients (n = 13) were selected from whom 
sufficient serial audiograms were obtained to analyze 
the regression of BPTA on age. The ATI (expressed 
in decibels per year) is the regression coefficient. An 
example of serial audiograms is shown in Fig 1. 
Histograms and probit plots (not shown) indicated 
the existence of two separate clusters of ATI values, 
those pertaining to cases without apparent progres­
sion (tentative type II, with a low ATI) and those 
pertaining to cases with a substantial ATI (tentative 
type III).
There were 3 patients with an ATI value that 
differed significantly from zero; ie, they showed
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.25 .5 1 2 4 8 kHz
-10
0
20
Fig 1. Serial audiograms of subject C6. Mean of 
right and left hearing levels (air conduction 
threshold, decibels hearing level) is shown. Re­
gression line (bin aural pure tone average [BPTA] 
on age) calculated from these values is y = 1,3 lx
•+ 42.7 (r = .95 for n = 6, p = .0030), which
indicates annual threshold increase (ATI) of 
about 1.3 dB/y (Table 3).
40
60
80
100
120 
dB HL
significant correlation and regression (Table 3): C5, 
C6 (also see Fig 1), and Fl 1; their ATI was in excess 
of 1 dB/y. The continuous fat lines connecting the 
separate data points for these 3 patients are shown in 
Fig 2 to illustrate the progressive character of their 
hearing loss.
Analysis of variance on all of our cases with an ATI 
value available (n = 13) demonstrated that these
values showed significant heterogeneity (F = 2,44, df
12 and 22, p = .033)* A similar analysis showed 
significant heterogeneity (F = 2.01»d f  19 and 31, p = 
.041) also for the combination of the present group of 
patients with known ATI and the cases previously 
described by others for whom regression analysis 
could be performed and an ATI value could be 
obtained (Table 4 15'18), All of the latter cases had a 
progressive type of hearing loss reported to be type III 
Usher’s syndrome, except for case 1 ofKarjalainenet 
al.16 Of interest, an analysis of variance performed on 
the previously reported cases and our own cases (ie, 
C5, C6, and FI 1) for whom ATI was in the range of 
1 to 5 dB/y, ie, those who showed the most convinc-
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ing progression of hearing loss, failed to show any 
significant heterogeneity in ATI values (F = 1.20, df
6 and 15, p = ,36; after the exclusion of the case of 
Gorlin et al15 —  because of its large SD —  F = 2.07, 
df5  and 14, p = .13),
DISCUSSION
There is little doubt that there is substantial varia­
tion in the Usher’s 2A audiologic phenotype, and at 
least two different patterns are apparent: one stable to 
slowly progressive, ie, in keeping with normal pres­
bycusis,19 and another more rapidly progressive. 
Progression was not apparent from the medical his­
tory. According to the x 2 test applied to the data 
presented in Table 2, the apparent audiologic pheno­
type did not appear to be associated with linked or 
unlinked subtypes, No evidence of families showing 
other than lq linkage was, in fact, observed. How­
ever, the phenotyping used, and thus the grouping of 
the families, was somewhat arbitrary. We therefore 
also performed analyses of variance on the ATI 
variable, ie, for those patients for whom sufficient 
follow-up data were available. The latter analyses on
• A1.A2
11 B3.B4
* C5.C6
i I D7.D8
E9,E10
4 F11,F12tF13 
A G14.G15 
x H16.H17
♦ 118,119,120 
Y K24.K25
*  M29
Fig 2. Plot of BPTA as measure of hearing loss 
against age forali of available data (Table 3). All 
separate dntn points axe shown. Continuous fat 
lines conncct individual longitudinal data in 3 
patients with significant progression as appar­
ent from their ATI (05, and FI !)• Dashed
other cases,
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TABLE 4. BINAURAL PURE TONE AVERAGE AND REGRESSION ON AGE FOR PREVIOUSLY REPORTED PATIENTS
FOR WHOM SUFFICIENT FOLLOW-UP DATA WERE AVAILABLE
Regression Parameters
Case Age and Binaural Audio logic ATI SD
Reference No. Pure Tone Average Phenotype Genotype r (dB/y) (dB/y)
Gorlin et al15 (One case) 4 y 57 dB HL; 5 y 85 dB HL; 
9 y 90 dB HL
m .75 5.07 4.41
Karjalainen et al16 Case 1 36 y 64 dB HL; 44 y 63 dB HL; 
51 y72  dB HL
n USH3* .79 0.518 0.405
Case 3 9 y 52 dB H L ;18y59 dB HL; 
32 y 72 dB HL
m USH3* 1.00 0,875 0.041
Case 4 10 y 86 dB HL; 24 y 102 dB HL; 
31 y 105 dB HL
III USH3* ,98 0.939 0.177
Case5 9 y 28 dB HL; 20 y 62 dB HL; 
27 y 71 dB HL
III 7* .98 2.45 0.487
Case 7 5 y 63 dB HL; 13y77  dB HL; 
17 y 113 dB HL
III 7* ,91 3.82 1.794
Case 8 7 y 59 dB HL; 8 y 75 dB HL; 
15 y 92 dB HL
III 7* .92 3.50 1,443
Sankila et al17 Case II-1 , 
family 15
7 y 55 dB HL; 8 y 80 dB HL;
10 y 97 dB HL; 18y98d B  HL; 
18 y 108 dB HL
m USH3 .80 3.08 1.338
Pakarinen et al18 Case II-5, 
family 7
35 y 73 dB HL; 42 y 
>1001* dB HL; 51 y 115 dB HL
hi USH2A* - 2.6
Italics indicate significant values,
*DrL. Pakarinen, personal communication 1995.
fNot measured at 2 and 4 kHz (pure tone average right ear).
the one hand clearly demonstrated heterogeneity in 
the progression of hearing loss in our patients, whereas 
on the other hand there was no significant difference 
in progression between our 3 cases with the most 
convincing progression and the similar cases previ­
ously reported for which sufficient data were avail­
able, Perhaps there is still lack of sufficient data, but 
it should be emphasized that 3 of our cases and 1 case 
previously reported (case 3 of Karjalainen et al16) 
showed significant progression*
The Dutch families are homogeneous with regard 
to linkage, and all are type 2 A. Thus, the source of 
variation in audiologic phenotype seen here is not due
to different mutations at different USH loci (insofar 
as presently known and therefore screened in our 
patients).
These results argue only that phenotypic variation 
in terms of the progression of hearing loss occurs 
within the Usher’s 2A sample of families. There is 
only a single previous report that noted no difference 
between the hearing loss seen in type 2A versus 2B .10 
Thus, an investigation into possible audiologic dif­
ferences between the type 2A and 2B subtypes is in 
order.
There are no linkage data published from families 
with the tentative clinical “type III Usher’s / ’ ie,
BPTA (dB HL)
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Fig 3. Plot of BPTA against age for previously 
reported patients, most of whom have disease 
designated as Usher’s type III, with sufficient 
follow-up data to allow regression (solid lines) 
or trend (dashed lines) analysis (Table 4). Data 
for patients II-2, 11*4, and II-5 were obtained 
from Dr L. Pakarincn (family 7, personal com­
munication 1995).
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progressive hearing loss, such as the patients de­
scribed by Gorlin et al15 and Karjalainen et al16 whose
USH3. It seems that we have to face the situation that 
not only Usher’s III patients but also Usher’s 2A
hearing data were included in the present analysis patients show, or may show, progression of hearing
m -M ^  I V  A  t a  Æ
(Fig 3 and Table 4), with one exception. Most re­ loss. Nevertheless, more detailed and more numerous
cently, in the Finnish population Usher’s syndrome data on the audiologic features of Usher’s III patients,
-  _ k  a  ^  à  ^  ^  ^  .  _
type III has been linked to chromosome 3q (USH3 
locus),17 and some of the cases included in our
also based on gene linkage results, will be needed to 
conclude more precisely whether those types can be
analysis (Table 4 and Fig 3) recently turned out to be divided clinically only on audiometric data.
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